Home › NDC Lookup › RxCUI directory › RxCUI 2712709

6.5 ML nipocalimab-aahu 185 MG/ML Injection [Imaavy] — RxCUI 2712709

Name: 6.5 ML nipocalimab-aahu 185 MG/ML Injection [Imaavy] (RxCUI 2712709)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2712709 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2712709

Official name6.5 ML nipocalimab-aahu 185 MG/ML Injection [Imaavy]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asImaavy 1200 MG per 6.5 ML Injection; imaavy 1,200 MG in 6.5 ML Injection

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)13 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nipocalimab-Aahu: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Imaavy is a treatment, not a cure. It works by lowering the harmful antibodies that cause your symptoms — whether that's the muscle weakness of myasthenia gravis or the red blood c...
What exactly is Imaavy treating — is it a cure or just controlling my condition?
That depends on your condition. For myasthenia gravis, after your first infusion you'll come in every two weeks for maintenance infusions. For warm autoimmune hemolytic anemia, mai...
How often do I have to come in for infusions, and how long does each one take?

📖 Read our full Nipocalimab-Aahu guide →

🕸️ Concept Web — How 6.5 ML nipocalimab-aahu 185 MG/ML Injection [Ima... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 6.5 ML nipocalimab-aahu 185 MG/ML Injection [Imaavy] RxCUI 2712709 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Nipocalimab 2712693 IN
- Nipocalimab-aahu 2712692 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Imaavy 2712701 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Nipocalimab Injection 2712696 SCDF
- Nipocalimab-aahu Injection 2712698 SCDFP
- Nipocalimab Injectable Product 2712695 SCDG
- Nipocalimab-aahu Injectable Product 2712697 SCDGP
- Nipocalimab Injection [Imaavy] 2712704 SBDF
- Nipocalimab-aahu Injection [Imaavy] 2712705 SBDFP
- Imaavy Injectable Product 2712703 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 6.5 ML nipocalimab-aahu 185 MG/ML Injection 2712708 SCD
- Nipocalimab-aahu 185 MG/ML 2712694 SCDC
- Nipocalimab-aahu 185 MG/ML [Imaavy] 2712702 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

6.5 ML nipocalimab-aahu 185 MG/ML Injection SCD · 2712708
Nipocalimab-aahu 185 MG/ML SCDC · 2712694
Nipocalimab Injection SCDF · 2712696
Nipocalimab-aahu Injection SCDFP · 2712698
Nipocalimab Injectable Product SCDG · 2712695
Nipocalimab-aahu Injectable Product SCDGP · 2712697

Brand-Name Concepts

Nipocalimab-aahu 185 MG/ML [Imaavy] SBDC · 2712702
Nipocalimab Injection [Imaavy] SBDF · 2712704
Nipocalimab-aahu Injection [Imaavy] SBDFP · 2712705
Imaavy Injectable Product SBDG · 2712703
Imaavy BN · 2712701

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 2712709 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
57894-0800-01	1 VIAL, SINGLE-DOSE in 1 BOX (57894-800-01) / 1.62 mL in 1...	IMAAVY	Janssen Biotech, Inc.	2025-04-29
57894-0801-01	1 VIAL, SINGLE-DOSE in 1 BOX (57894-801-01) / 6.5 mL in 1 V...	IMAAVY	Janssen Biotech, Inc.	2025-04-29

Observed labelers: Janssen Biotech, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9256	Inj, nipocalimab-aahu, 3 mg	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.